Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of Hepatitis C Virus Infections Among Patients of Ukrainian Origin During the Influx of War Refugees to Poland.
Flisiak R, Zarębska-Michaluk D, Martonik D, Janocha-Litwin J, Berak H, Sitko M, Mazur W, Janczewska E, Lorenc B, Klapaczyński J, Laurans Ł, Dybowska D, Piekarska A, Tudrujek-Zdunek M, Dobrowolska K, Parfieniuk-Kowerda A. Flisiak R, et al. Among authors: tudrujek zdunek m. J Clin Med. 2024 Dec 15;13(24):7641. doi: 10.3390/jcm13247641. J Clin Med. 2024. PMID: 39768565 Free PMC article.
Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide.
Berkan-Kawińska A, Piekarska A, Berak H, Mazur W, Garlicki A, Tudrujek-Zdunek M, Lorenc B, Dybowska D, Socha Ł, Parfieniuk-Kowerda A, Flisiak R. Berkan-Kawińska A, et al. Among authors: tudrujek zdunek m. Clin Exp Hepatol. 2024 Sep;10(3):165-169. doi: 10.5114/ceh.2024.141752. Epub 2024 Jul 29. Clin Exp Hepatol. 2024. PMID: 39697370 Free PMC article.
Correction: Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination.
Zarębska-Michaluk D, Brzdęk M, Tronina O, Janocha-Litwin J, Sitko M, Piekarska A, Klapaczyński J, Parfieniuk-Kowerda A, Sobala-Szczygieł B, Tudrujek-Zdunek M, Laurans Ł, Flisiak R. Zarębska-Michaluk D, et al. Among authors: tudrujek zdunek m. BMC Med. 2024 Nov 8;22(1):524. doi: 10.1186/s12916-024-03753-w. BMC Med. 2024. PMID: 39516834 Free PMC article. No abstract available.
Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination.
Zarębska-Michaluk D, Brzdęk M, Tronina O, Janocha-Litwin J, Sitko M, Piekarska A, Klapaczyński J, Parfieniuk-Kowerda A, Sobala-Szczygieł B, Tudrujek-Zdunek M, Laurans Ł, Flisiak R. Zarębska-Michaluk D, et al. Among authors: tudrujek zdunek m. BMC Med. 2024 Oct 23;22(1):486. doi: 10.1186/s12916-024-03699-z. BMC Med. 2024. PMID: 39444018 Free PMC article.
The Real-World Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C in Patients Active Malignancies.
Dąbrowska M, Jaroszewicz J, Sitko M, Janocha-Litwin J, Zarębska-Michaluk D, Janczewska E, Lorenc B, Tudrujek-Zdunek M, Parfieniuk-Kowerda A, Klapaczyński J, Berak H, Socha Ł, Dobracka B, Dybowska D, Mazur W, Ważny Ł, Flisiak R. Dąbrowska M, et al. Among authors: tudrujek zdunek m. Cancers (Basel). 2024 Sep 9;16(17):3114. doi: 10.3390/cancers16173114. Cancers (Basel). 2024. PMID: 39272972 Free PMC article.
Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices.
Brzdęk M, Zarębska-Michaluk D, Kukla M, Janocha-Litwin J, Dybowska D, Janczewska E, Lorenc B, Berak H, Mazur W, Tudrujek-Zdunek M, Klapaczyński J, Piekarska A, Sitko M, Laurans Ł, Parfieniuk-Kowerda A, Flisiak R. Brzdęk M, et al. Among authors: tudrujek zdunek m. Pharmacol Rep. 2024 Oct;76(5):1114-1129. doi: 10.1007/s43440-024-00639-9. Epub 2024 Aug 20. Pharmacol Rep. 2024. PMID: 39162985 Free PMC article.
Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure.
Tronina O, Brzdęk M, Zarębska-Michaluk D, Lorenc B, Janocha-Litwin J, Berak H, Sitko M, Dybowska D, Mazur W, Tudrujek-Zdunek M, Janczewska E, Klapaczyński J, Dobracki W, Parfieniuk-Kowerda A, Krygier R, Socha Ł, Flisiak R. Tronina O, et al. Among authors: tudrujek zdunek m. Clin Exp Hepatol. 2023 Dec;9(4):320-334. doi: 10.5114/ceh.2023.133307. Epub 2023 Dec 15. Clin Exp Hepatol. 2023. PMID: 38774196 Free PMC article.
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients.
Piekarska A, Berkan-Kawińska A, Berak H, Mazur W, Sitko M, Parfieniuk-Kowerda A, Lorenc B, Dybowska D, Janczewska E, Janocha-Litwin J, Dobracka B, Socha Ł, Tudrujek-Zdunek M, Flisiak R. Piekarska A, et al. Among authors: tudrujek zdunek m. Expert Rev Anti Infect Ther. 2024 Sep;22(9):775-780. doi: 10.1080/14787210.2024.2353691. Epub 2024 May 16. Expert Rev Anti Infect Ther. 2024. PMID: 38722307
Effectiveness and safety of direct-acting antivirals in the therapy of HCV-infected elderly people.
Brzdęk M, Zarębska-Michaluk D, Tomasiewicz K, Tudrujek-Zdunek M, Lorenc B, Mazur W, Berak H, Janocha-Litwin J, Klapaczyński J, Sitko M, Janczewska E, Dybowska D, Parfieniuk-Kowerda A, Piekarska A, Jaroszewicz J, Flisiak R. Brzdęk M, et al. Among authors: tudrujek zdunek m. Minerva Med. 2024 Jun;115(3):266-276. doi: 10.23736/S0026-4806.24.09238-3. Epub 2024 Apr 9. Minerva Med. 2024. PMID: 38591836
Direct-acting antivirals in women of reproductive age infected with hepatitis C virus.
Dobrowolska K, Pawłowska M, Zarębska-Michaluk D, Rzymski P, Janczewska E, Tudrujek-Zdunek M, Berak H, Mazur W, Klapaczyński J, Lorenc B, Janocha-Litwin J, Parfieniuk-Kowerda A, Dybowska D, Piekarska A, Krygier R, Dobracka B, Jaroszewicz J, Flisiak R. Dobrowolska K, et al. Among authors: tudrujek zdunek m. J Viral Hepat. 2024 Jun;31(6):309-319. doi: 10.1111/jvh.13936. Epub 2024 Mar 14. J Viral Hepat. 2024. PMID: 38483035
39 results